Clinical Trial: Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Urothelial Carcinoma
Study Type: INTERVENTIONAL
Official Title: Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma After Prior Chemotherapy: a Open-label, Multicenter Phase II Study (UTRUST)
Brief Summary:
This study is a open-label, multicenter, phase II study to evaluate the efficacy and safety of utidelone in the recurrent or metastatic urothelial carcinoma after prior chemotherapy.
Read more